Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kester

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
Tissue Antigens|July 24, 2009
New tools to monitor the impact of viral infection on the alloreactive T-cell repertoireL J D'Orsogna, A L Amir, Y M Zoet, et al.
Cancer Research|November 11, 2010
High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanningCornelis A M Van Bergen, Caroline E Rutten, Edith D Van Der Meijden, et al.
Leukemia|February 20, 2004
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cellsF M Kloosterboer, S A P van Luxemburg-Heijs, R A van Soest, et al.
Haematologica|June 22, 2010
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infectionMaarten L Zandvliet, J H Frederik Falkenburg, Ellis van Liempt, et al.
Plos One|November 17, 2012
Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null miceWendy W J Unger, Todd Pearson, Joana R F Abreu, et al.
Blood|January 20, 2007
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.
Proteomics|December 19, 2017
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell SurfaceHelena M Bijen, Chopie Hassan, Michel G D Kester, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Human T cells recognize HLA-DP-bound peptides in two orientationsSebastian Klobuch, Jia Jia Lim, Peter van Balen, et al.
Blood|January 6, 2017
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1Lorenz Jahn, Pleun Hombrink, Renate S Hagedoorn, et al.
Journal for Immunotherapy of Cancer|December 9, 2024
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantationKyra J Fuchs, Marcus Göransson, Michel G D Kester, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Tissue Antigens|July 24, 2009
New tools to monitor the impact of viral infection on the alloreactive T-cell repertoireL J D'Orsogna, A L Amir, Y M Zoet, et al.
Cancer Research|November 11, 2010
High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanningCornelis A M Van Bergen, Caroline E Rutten, Edith D Van Der Meijden, et al.
Leukemia|February 20, 2004
Direct cloning of leukemia-reactive T cells from patients treated with donor lymphocyte infusion shows a relative dominance of hematopoiesis-restricted minor histocompatibility antigen HA-1 and HA-2 specific T cellsF M Kloosterboer, S A P van Luxemburg-Heijs, R A van Soest, et al.
Haematologica|June 22, 2010
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infectionMaarten L Zandvliet, J H Frederik Falkenburg, Ellis van Liempt, et al.
Plos One|November 17, 2012
Islet-specific CTL cloned from a type 1 diabetes patient cause beta-cell destruction after engraftment into HLA-A2 transgenic NOD/scid/IL2RG null miceWendy W J Unger, Todd Pearson, Joana R F Abreu, et al.
Blood|January 20, 2007
Multiple myeloma-reactive T cells recognize an activation-induced minor histocompatibility antigen encoded by the ATP-dependent interferon-responsive (ADIR) geneCornelis A M van Bergen, Michel G D Kester, Inge Jedema, et al.
Proteomics|December 19, 2017
Specific T Cell Responses against Minor Histocompatibility Antigens Cannot Generally Be Explained by Absence of Their Allelic Counterparts on the Cell SurfaceHelena M Bijen, Chopie Hassan, Michel G D Kester, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2022
Human T cells recognize HLA-DP-bound peptides in two orientationsSebastian Klobuch, Jia Jia Lim, Peter van Balen, et al.
Blood|January 6, 2017
TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor BOB1Lorenz Jahn, Pleun Hombrink, Renate S Hagedoorn, et al.
Journal for Immunotherapy of Cancer|December 9, 2024
DNA barcoded peptide-MHC multimers to measure and monitor minor histocompatibility antigen-specific T cells after allogeneic stem cell transplantationKyra J Fuchs, Marcus Göransson, Michel G D Kester, et al.
Pageof 17